1. Home
  2. EXAS vs WTRG Comparison

EXAS vs WTRG Comparison

Compare EXAS & WTRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • WTRG
  • Stock Information
  • Founded
  • EXAS 1995
  • WTRG 1901
  • Country
  • EXAS United States
  • WTRG United States
  • Employees
  • EXAS N/A
  • WTRG N/A
  • Industry
  • EXAS Medical Specialities
  • WTRG Water Supply
  • Sector
  • EXAS Health Care
  • WTRG Utilities
  • Exchange
  • EXAS Nasdaq
  • WTRG Nasdaq
  • Market Cap
  • EXAS 10.5B
  • WTRG 9.6B
  • IPO Year
  • EXAS N/A
  • WTRG N/A
  • Fundamental
  • Price
  • EXAS $51.74
  • WTRG $35.06
  • Analyst Decision
  • EXAS Strong Buy
  • WTRG Buy
  • Analyst Count
  • EXAS 16
  • WTRG 6
  • Target Price
  • EXAS $72.80
  • WTRG $43.00
  • AVG Volume (30 Days)
  • EXAS 2.2M
  • WTRG 1.5M
  • Earning Date
  • EXAS 02-19-2025
  • WTRG 02-26-2025
  • Dividend Yield
  • EXAS N/A
  • WTRG 3.72%
  • EPS Growth
  • EXAS N/A
  • WTRG 10.16
  • EPS
  • EXAS N/A
  • WTRG 1.99
  • Revenue
  • EXAS $2,692,328,000.00
  • WTRG $1,961,149,000.00
  • Revenue This Year
  • EXAS $11.81
  • WTRG $7.80
  • Revenue Next Year
  • EXAS $11.52
  • WTRG $8.54
  • P/E Ratio
  • EXAS N/A
  • WTRG $17.60
  • Revenue Growth
  • EXAS 11.91
  • WTRG N/A
  • 52 Week Low
  • EXAS $40.62
  • WTRG $33.18
  • 52 Week High
  • EXAS $79.62
  • WTRG $41.78
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 35.28
  • WTRG 38.38
  • Support Level
  • EXAS $49.79
  • WTRG $34.14
  • Resistance Level
  • EXAS $60.88
  • WTRG $36.64
  • Average True Range (ATR)
  • EXAS 2.67
  • WTRG 0.65
  • MACD
  • EXAS -0.59
  • WTRG 0.02
  • Stochastic Oscillator
  • EXAS 17.58
  • WTRG 51.51

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About WTRG Essential Utilities Inc.

Essential Utilities is a Pennsylvania-based holding company for us water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Nearly three fourths of its water earnings come from Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. Essential exited its noncore competitive water and energy services businesses.

Share on Social Networks: